Form 4: Insmed Inc. Executive Sells Shares Under 10b5-1 Trading Plan

Insmed Inc.'s Chief People Strategy Officer, S. Nicole Schaeffer, sold 872 shares of common stock at $68.72 per share under a pre-arranged 10b5-1 trading plan.

Summary

• S. Nicole Schaeffer, Chief People Strategy Officer at Insmed Inc., sold 872 shares of common stock on January 14, 2025.
• The sale was executed at a price of $68.72 per share.
• This transaction was conducted under a pre-established 10b5-1 trading plan.
• Following the transaction, Ms. Schaeffer directly owns 97,083 shares of Insmed Inc. common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction under a pre-arranged trading plan, indicating a neutral sentiment.

Industry Context

This is a routine transaction for an executive and is not unusual. It is common for executives to use 10b5-1 trading plans to avoid accusations of insider trading.

Comparison to Industry Standards

• Executive stock sales are a common occurrence in publicly traded companies.
• The use of 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations.
• The volume of shares sold is relatively small compared to the total outstanding shares of Insmed Inc.

Stakeholder Impact

• The impact on shareholders is likely to be minimal given the small volume of shares sold.

Key Dates

Keywords

Insmed Inc, stock sale, 10b5-1 trading plan, executive stock transaction, S. Nicole Schaeffer, share sale, INSM